Prognostic value of HFA-ICOS risk assessment for cancer therapy-related cardiovascular toxicity in adults with acute lymphoblastic leukemia. Valdovinos-Elizalde LE, Rios-Olais FA, Hernandez-Felix JH, Vasquez-Ortiz ZY, et al. Leuk Lymphoma 2025 Nov 11:1-9. doi: 10.1080/10428194.2025.2583445.

Read + Share

Amedeo Smart

Independent Medical Education

Valdovinos-Elizalde LE, Rios-Olais FA, Hernandez-Felix JH, Vasquez-Ortiz ZY, et al. Prognostic value of HFA-ICOS risk assessment for cancer therapy-related cardiovascular toxicity in adults with acute lymphoblastic leukemia. Leuk Lymphoma 2025 Nov 11:1-9. doi: 10.1080/10428194.2025.2583445.
PMID: 41217040